F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000. Leukemia, Immunotherapy, Immune System, Genetic Engineering, Cancer, Children's Hospital of Philadelphia, Food and Drug Administration, Novartis AG, University of Pennsylvania, June, Carl H, Whitehead, Emma, Children and Childhood, Drugs (Pharmaceuticals)